Here Are Several Promising Rare Disease Stocks

These small biotech concerns are undervalued.

Hormel Foods Is Still Attractive With a New Technical Strategy

Let's check out the charts and indicators again on HRL.

Chinese Sweet Talk, Banks Perk Up, and a Swing at Cintas: Market Recon

Plus, a look at the uncertain prospects for a Saudi Aramco initial public offering.

Some Resolution to China Trade Will Be a Relief but 'Sell the News' Danger Lurks

If the market keeps running up into the meeting between Trump and Liu the potential for some profit taking in front of the weekend will be quite high.

Get Ready for FedEx to Deliver

The FDX decline can't go on forever, and after its Wednesday lows, it's way too cheap to stay grounded.

Trump Says Talks Are Going Well, and the Machines Buy It -- Again

Enough theatrics, back to fundamentals.

Which Way Will We Break Out? You Tell Me

So far, according to my Twitter poll on which way we break out of the S&P 500's trading range, it's nearly half and half; plus, here are some of the indicator changes I've spotted.

Kass: My Top 10 List of Market Concerns

The unlikely resolution of our trade differences with China is only one of the many challenges facing investors.

Let's Make a ... Mini-Deal?

The big question that the market will face Friday is whether we will have a 'sell the news' reaction to the announcement of a China trade deal -- even a tiny one.

Jim Cramer: What Would Make a Good Stock in This Environment?

Let me give you the items I want to see before I bless buying anything in what has become a plain, out and out, treacherous market.